# Prestige Consumer Healthcare Inc. (PBH)

**Exchange:** NYSE  
**Sector:** Healthcare  
**Market cap:** $2.39B  
**Price:** $49.13 (+0.97%)

> Prestige Consumer Healthcare Inc. is a corporation involved in the production and distribution of over-the-counter healthcare and household cleaning products. This company primarily focuses on providing solutions for everyday health and wellness needs. It operates within the consumer staples sector, influencing industries such as healthcare, wellness, and personal care goods. Prestige Consumer Healthcare Inc. offers a range of well-known products that cater to personal health care, featuring brands that span various categories, including analgesics, cough and cold remedies, gastrointestinal aids, and oral care products. The company sells its products through multiple channels including drug stores, groceries, and e-commerce platforms, reaching a broad consumer base. Prestige Consumer Healthcare Inc.'s role in the market centers on addressing consumer demands for accessible and reliable healthcare products, reinforcing its significance as a key player in enhancing and maintaining health across diverse demographics.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $1.09B | $596M | $309M | $190M | — |
| 2025 | $1.14B | $634M | $337M | $215M | — |
| 2024 | $1.13B | $624M | $342M | $209M | — |
| 2023 | $1.13B | $625M | -$22M | -$82M | — |
| 2022 | $1.09B | $621M | $330M | $205M | — |
| 2021 | $943M | $547M | $297M | $165M | — |
| 2020 | $963M | $552M | $291M | $142M | — |
| 2019 | $976M | $556M | $68M | -$36M | — |
| 2018 | $1.04B | $577M | $215M | $340M | — |
| 2017 | $882M | $500M | $206M | $69M | — |
| 2016 | $806M | $467M | $260M | $100M | — |
| 2015 | $713M | $406M | $208M | $78M | — |
| 2014 | $596M | $336M | $189M | $73M | — |
| 2013 | $617M | $344M | $192M | $66M | — |
| 2012 | $441M | $227M | $103M | $37M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2026 | $3.49B | $1.61B | $1.89B | $64M | $994M |
| 2025 | $3.40B | $1.57B | $1.83B | $98M | $992M |
| 2024 | $3.32B | $1.66B | $1.66B | $46M | $1.13B |
| 2023 | $3.35B | $1.91B | $1.45B | $58M | $1.35B |
| 2022 | $3.67B | $2.09B | $1.58B | $27M | $1.48B |
| 2021 | $3.43B | $2.07B | $1.36B | $32M | $1.48B |
| 2020 | $3.51B | $2.34B | $1.17B | $95M | $1.73B |
| 2019 | $3.44B | $2.35B | $1.10B | $28M | $1.80B |
| 2018 | $3.76B | $2.58B | $1.18B | $33M | $1.99B |
| 2017 | $3.91B | $3.09B | $823M | $42M | $2.19B |
| 2016 | $2.95B | $2.20B | $744M | $27M | $1.63B |
| 2015 | $2.64B | $2.01B | $628M | $21M | $1.56B |
| 2014 | $1.80B | $1.23B | $563M | $28M | $934M |
| 2013 | $1.74B | $1.26B | $478M | $16M | $971M |
| 2012 | $1.76B | $1.36B | $403M | $19M | $1.12B |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2026 | $258M | $11M | $246M |
| 2025 | $252M | $8M | $243M |
| 2024 | $249M | $10M | $239M |
| 2023 | $230M | $8M | $222M |
| 2022 | $260M | $10M | $250M |
| 2021 | $236M | $22M | $213M |
| 2020 | $217M | $15M | $203M |
| 2019 | $189M | $10M | $179M |
| 2018 | $210M | $13M | $198M |
| 2017 | $149M | $3M | $146M |
| 2016 | $176M | $4M | $173M |
| 2015 | $156M | $6M | $150M |
| 2014 | $112M | $3M | $109M |
| 2013 | $138M | $10M | $127M |
| 2012 | $67M | $606,000 | $67M |

Source: [CompaniesByCap](https://companiesbycap.com/company/PBH)